NOVO NORDISK A S (NVO)
A+
Pipeline Grade
Drug Pipeline (7 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
SEMAGLUTIDE
WEGOVY |
APPROVED | Abdominal Donor-site, Abdominal Obesity, Abnormality in Synovial Tissue, Achondroplasia, Acquired Bleeding Disorder, Acquired Haemophilia, Acute Cellular Graft Rejection, Acute Kidney Injury, Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Admitting Hospital, Adult Growth Hormone Deficiency, Aging, Albuminuria, Alcohol Use Disorder, Alcohol Use Disorder (AUD), Alcohol-related Liver Disease, Alpha 1-Antitrypsin Deficiency, Alpha-Synucleinopathy, Androgen Deprivation Therapy, Anorexia Nervosa, Anterior Pituitary Hyposecretion Syndrome, Arterial Hypertension, Asthma, Atherosclerosis, Atherosclerosis Cardiovascular Disease, Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Atrophic Vaginitis, Autonomic Failure, Autonomic Neuropathy, Diabetic, Bariatric Surgery, Binge-Eating Disorder, Bleeding, Bleeding Disorder, Bleeding During/Following Surgery, Body Esteem, Bone Fracture, Born Small for Gest |
|
INSULIN DEGLUDEC, LIRAGLUTIDE
XULTOPHY 100/3.6 |
APPROVED | — |
|
LIRAGLUTIDE
SAXENDA |
APPROVED | — |
|
INSULIN DEGLUDEC
TRESIBA |
APPROVED | — |
|
INSULIN ASPART
FIASP FLEXTOUCH |
APPROVED | — |
|
NEDOSIRAN SODIUM
RIVFLOZA |
APPROVED | — |
|
INSULIN ASPART, INSULIN DEGLUDEC
RYZODEG 70/30 |
NDA | — |
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-21 | Phase2 Readout | — |
| 2026-09-03 | Phase1 Readout | — |
| 2026-09-24 | Phase1 Readout | — |
| 2026-12-14 | Phase2 Readout | — |
| 2026-12-31 | Phase2 Readout | — |
| 2027-01-21 | Phase1 Readout | — |
| 2027-02-05 | Phase1 Readout | — |
| 2027-04-08 | Phase1 Readout | — |
| 2027-04-13 | Phase1 Readout | — |
| 2027-05-14 | Phase1 Readout | — |
| 2027-05-16 | Phase2 Readout | — |
| 2027-05-30 | Phase1 Readout | — |
Active Clinical Trials (50)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07246421 | Glucagon Resistance in Patients With MASLD and T2DM | OTHER | Recruiting | 24 |
| NCT06752967 | Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) | OTHER | Recruiting | 45 |
| NCT07404150 | Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity | OTHER | Enrolling By Invitation | 60 |
| NCT06745011 | Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System | OTHER | Enrolling By Invitation | 100 |
| NCT05689372 | Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Pat... | OTHER | Enrolling By Invitation | 600 |
| NCT05441267 | A Study of Cardiovascular Events iN Diabetes Plus | PHASE4 | Active Not Recruiting | 21,296 |
| NCT07055607 | A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice | OTHER | Enrolling By Invitation | 1,250 |
| NCT06291805 | Phenotyping and Characterization of wtATTR-CM (TRACE 1) | OTHER | Recruiting | 120 |
| NCT04682145 | Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol | OTHER | Enrolling By Invitation | 50 |
| NCT05195944 | Semaglutide vs Sitagliptin | PHASE4 | Enrolling By Invitation | 58 |
| NCT07191925 | An Evaluation of "Growing Healthy Places: Mississauga" | OTHER | Active Not Recruiting | 4,900 |
| NCT07237685 | Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus | OTHER | Recruiting | 1,000 |
| NCT06122441 | RE-inventing Strategies for Healthy Ageing; Recommendations and Tools | OTHER | Active Not Recruiting | 119 |
| NCT06831734 | Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo | OTHER | Enrolling By Invitation | 30 |
| NCT07500610 | Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact on Heart and Mobility Health: PANACEA-O. | OTHER | Recruiting | 50 |
| NCT01239550 | Insulin Detemir in Obesity Management | OTHER | Active Not Recruiting | 240 |
| NCT06285071 | Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemoph... | OTHER | Enrolling By Invitation | 23 |
| NCT05621746 | An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct | OTHER | Recruiting | 100 |
| NCT05872022 | A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy | OTHER | Enrolling By Invitation | 728 |
| NCT05569980 | The Nordic Rectal Prolapse Study | OTHER | Enrolling By Invitation | 430 |
| NCT06269120 | SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, a... | OTHER | Recruiting | 470 |
| NCT07532863 | A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part... | OTHER | Recruiting | 400 |
| NCT07160816 | A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar | OTHER | Active Not Recruiting | 245 |
| NCT03308916 | Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers | OTHER | Recruiting | 6,500 |
| NCT07154238 | Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sec... | OTHER | Enrolling By Invitation | 2,546 |
| NCT05283512 | Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanc... | OTHER | Recruiting | 254 |
| NCT05503927 | A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy | OTHER | Enrolling By Invitation | 1,139 |
| NCT05308927 | French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome | OTHER | Enrolling By Invitation | 221 |
| NCT05768958 | Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing | OTHER | Active Not Recruiting | 58 |
| NCT06222151 | Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization | OTHER | Recruiting | 112 |
| NCT05780905 | Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes | PHASE4 | Recruiting | 50 |
| NCT05718570 | A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Infor... | OTHER | Enrolling By Invitation | 400 |
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | OTHER | Recruiting | 10,000 |
| NCT03972345 | Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth H... | OTHER | Enrolling By Invitation | 750 |
| NCT01511393 | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | OTHER | Enrolling By Invitation | 6,750 |
| NCT04775082 | SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity | PHASE3 | Active Not Recruiting | 78 |
| NCT07227246 | Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 | PHASE3 | Recruiting | 350 |
| NCT04624659 | A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) | PHASE3 | Active Not Recruiting | 450 |
| NCT05330325 | A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow | PHASE3 | Active Not Recruiting | 412 |
| NCT07253285 | A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight | PHASE3 | Recruiting | 460 |
| NCT07571005 | AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst... | PHASE3 | Recruiting | 300 |
| NCT04042402 | Long Term Extension Study in Patients With Primary Hyperoxaluria | PHASE3 | Active Not Recruiting | 75 |
| NCT07301034 | A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo,... | PHASE3 | Recruiting | 332 |
| NCT07271251 | A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the... | PHASE3 | Active Not Recruiting | 264 |
| NCT05135559 | A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors | PHASE3 | Active Not Recruiting | 153 |
| NCT07276282 | Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction | PHASE3 | Recruiting | 332 |
| NCT07509307 | AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee... | PHASE3 | Recruiting | 400 |
| NCT04083781 | Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors | PHASE3 | Active Not Recruiting | 134 |
| NCT06797869 | A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful ... | PHASE2 | Active Not Recruiting | 142 |
| NCT06198712 | A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease | PHASE2 | Recruiting | 95 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.